Defining the metabolomic profile associated with early cardiotoxicity in patients with breast cancer treated with anthracyclines

被引：0
|
作者：
Cocco, D. [1 ]
Ferro, E. G. [2 ]
Ricci, S. [1 ]
Deidda, M. [1 ]
Noto, A. [1 ]
Madeddu, C. [1 ]
Atzori, F. [1 ]
Scarlozzi, M. [1 ]
Mercuro, G. [1 ]
Dessalvi, C. Cadeddu [1 ]
机构：
[1] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3289 / 3289
页数：1
相关论文
共 50 条
  • [31] Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
    Todorova, Valentina K.
    Azhar, Gohar
    Stone, Annjanette
    Malapati, Sindhu J.
    Che, Yingni
    Zhang, Wei
    Makhoul, Issam
    Wei, Jeanne Y.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [32] Plasma metabolomic profile associated with fatigue in cancer patients
    Feng, Li Rebekah
    Barb, Jennifer J.
    Regan, Jeniece
    Saligan, Leorey N.
    CANCER MEDICINE, 2021, 10 (05): : 1623 - 1633
  • [33] Can We Abandon Anthracyclines for Early Breast Cancer Patients?
    Henderson, I. Craig
    ONCOLOGY-NEW YORK, 2011, 25 (02): : 115 - 127
  • [34] Anthracyclines in childhood cancer: low overall incidence of early cardiotoxicity
    Reactions Weekly, 1997, 652 (1) : 4 - 4
  • [35] Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines
    Vassilomanolakis, M
    Koumakis, G
    Barbounis, V
    Demiri, M
    Pateras, H
    Efremidis, AP
    ANNALS OF ONCOLOGY, 2000, 11 (09) : 1155 - 1160
  • [36] Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane
    Mavinkurve-Groothuis, Annelies M. C.
    de Baat, Esmee C.
    Feijen, Elizabeth A. M.
    Kremer, Leontien C. M.
    Armenian, Saro H.
    Mulder, Renee L.
    van Dalen, Elvira C.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (10)
  • [37] METABOLOMIC FINGERPRINT IS ABLE TO IDENTIFY PATIENTS AT RISK TO DEVELOP ANTHRACYCLINES-INDUCED CARDIOTOXICITY
    Deidda, Martino
    Fazzini, Luca
    Campana, Nicola
    Licciardi, Marco
    Mercuro, Giuseppe
    Cadeddu, Christian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2281 - 2281
  • [38] Cancer and Cardiovascular Disease: the Use of Novel Echocardiography Measures to Predict Subsequent Cardiotoxicity in Breast Cancer Treated with Anthracyclines and Trastuzumab
    Gulati G.
    Zhang K.W.
    Scherrer-Crosbie M.
    Ky B.
    Current Heart Failure Reports, 2014, 11 (4) : 366 - 373
  • [39] Cardiotoxicity associated with the use of trastuzumab in breast cancer patients
    Perik, Patrick J.
    de Korte, Maarten Alexander
    van Veldhuisen, Dirk J.
    Gietema, Jourik A.
    Sleijfer, Dirk T.
    de Vries, Elisabeth G. E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (12) : 1763 - 1771
  • [40] EVALUATION OF EARLY DEXRAZOXANE USE AND CARDIOTOXICITY RISK IN PATIENTS WITH SOFT-TISSUE SARCOMA TREATED WITH ANTHRACYCLINES
    Jang, Kristine
    Wallins, Joseph S.
    Movva, Sujana
    Tsay, Annie
    Liu, Jennifer E.
    Yu, Anthony F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2351 - 2351
12345